The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.

Department of Nephrology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Nephrology and Renal Transplantation Patras University Hospital Patras Greece

Department of Nephrology Hospital Universitario Fundación Alcorcón Alcorcón Spain

Division of Diagnostics and Specialist Medicine Department of Health Medicine and Caring Sciences Linköping University Linköping Sweden

Division of Nephrology and Transplant Medicine Department of Medicine Leiden University Medical Center Leiden The Netherlands

Division of Nephrology Department of Clinical Sciences Lund Lund University and Skåne University Hospital Lund Sweden

Division of Nephrology Department of Internal Medicine Necmettin Erbakan University Konya Turkey

Division of Nephrology Medizinische Klinik und Poliklinik 4 Klinikum der Universität Munich Germany

Division of Nephrology RWTH Aachen University Hospital Aachen Germany

Division of Renal Medicine Department of Clinical Science Intervention and Technology Karolinska Institutet Stockholm Sweden

See more in PubMed

Guan WJ, Ni ZY, Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; doi:10.1056/NEJMoa2002032 PubMed PMC

Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506 PubMed PMC

Cheng Y, Luo R, Wang K. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020; pii: S0085-2538(20)30255-6. doi:10.1016/j.kint.2020.03.005 PubMed PMC

Naicker S, Yang CW, Hwang SJ. et al. The novel coronavirus 2019 epidemic and kidneys. Kidney Int 2020; pii: S0085-2538(20)30251-9. doi: 10.1016/j.kint.2020.03.001 PubMed PMC

Basile C, Combe C, Pizzarelli F. et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant 2020; pii: gfaa069. doi: 10.1093/ndt/gfaa069 PubMed PMC

Alberici F, Delbarba E, Manenti C. et al. Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection. Kidney Int Rep 2020; doi: 10.1016/j.ekir.2020.04.001 PubMed PMC

Rombola G, Heidempergher M, Pedrini L. et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol 2020; 33: 193–196 PubMed PMC

Madjid M, Safavi-Naeini P, Solomon SD. et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 2020; doi:10.1001/jamacardio.2020.1286 PubMed

Anders HJ, Andersen K, Stecher B.. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013; 83: 1010–1016 PubMed

Syed-Ahmed M, Narayanan M.. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis 2019; 26: 8–15 PubMed

Jardel S, Puechal XL, Quellec A. et al. Mortality in systemic necrotizing vasculitides: a retrospective analysis of the French Vasculitis Study Group registry. Autoimmun Rev 2018; 17: 653–659 PubMed

Teh CL, Wan SA, Ling GR.. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol 2018; 37: 2081–2086 PubMed

Sawalha AH, Manzi S.. Coronavirus disease-2019: implication for the care and management of patients with systemic lupus erythematosus. Eur J Rheum 2020; 7: 1–4 PubMed PMC

Ai T, Yang Z, Hou H. et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020; doi: 10.1148/radiol.2020200642 PubMed PMC

Long C, Xu H, Shen Q. et al. Diagnosis of the coronavirus disease (COVID-19): RRT-PCR or CT? Eur J Radiol 2020; 126: 108961. PubMed PMC

Zingone F, Savarino EV.. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Lancet Gastroenterol Hepatol 2020; pii: S2468-1253(20)30085-6. doi:10.1016/S2468-1253(20)30085-6 PubMed PMC

Ceribelli A, Motta F, De Santis M. et al. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun 2020; 109: 102442. PubMed PMC

Vaduganathan M, Vardeny O, Michel T. et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020;382:1653–1659 PubMed PMC

Brooks SK, Webster RK, Smith LE. et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–920 PubMed PMC

Carbajo-Lozoya J, Ma-Lauer Y, Malesevic M. et al. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including alisporivir. Virus Res 2014; 184: 44–53 PubMed PMC

Pfefferle S, Schopf J, Kogl M. et al. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 2011; 7: e1002331. PubMed PMC

Phua J, Weng L, Ling L. et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020; pii: S2213-2600(20)30161-2. doi: 10.1016/S2213-2600(20)30161-2 PubMed PMC

Sarzi-Puttini P, Giorgi V, Sirotti S. et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 2020; 38: 337–342 PubMed

Su H, Yang M, Wan C. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;doi:10.1016/j.kint.2020.04.003 PubMed PMC